Lapidus Stanley 4/A
4/A · Lucid Diagnostics Inc. · Filed Sep 27, 2023
Insider Transaction Report
Form 4/AAmended
Lapidus Stanley
Director
Transactions
- Sale
Common stock
2023-09-20$1.45/sh−3,405$4,937→ 132,051 total - Sale
Common stock
2023-09-20$1.44/sh−412$593→ 131,639 total - Sale
Common stock
2023-09-21$1.44/sh−100$144→ 131,539 total
Footnotes (3)
- [F1]Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
- [F2]Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.
- [F3]The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023.